Abstract | BACKGROUND: Patients with diabetes often do not reach recommended lipid targets. This may be in part due to the difficulty of obtaining fasting measurements. OBJECTIVE: RESEARCH DESIGN AND METHODS: Standard lipids and NMR lipoproteins were analyzed at baseline and following a standardized meal in patients with T2DM. OUTCOMES MEASURES: Primary outcomes were agreement between fasting and nonfasting LDLc, non-HDLc, and LDLP and the agreement between these measures for determining fasting LDLc treatment success. Direct LDL cholesterol (DLDL) was a secondary outcome. RESULTS: Of 31 patients, only 56% of LDLc measurements were equivalent in the fasting and nonfasting states, compared to 97% of DLDLc (p < 0.0001), 94% of non-HDLc (p < 0.001) and 77% of LDLP (p < 0.01) measurements. Assessment of nonfasting lipid values would have resulted in misclassification by treatment target in 15% of LDLc, 3.2% of DLDLc assessments (p < 0.05 vs. LDLc), and 0% of non-HDLc and LDLP assessments (p < 0.01 vs. LDLc). Nonfasting LDLc, non-HDLc, LDLP, and DLDLc correctly identified fasting LDLc classification in 23/27 (85%), 26/30 (87%, p = NS vs. nonfasting LDLc), 16/30 (53%, p < 0.001 vs. nonfasting LDLc), and 24/30 (80%, p = NS vs. nonfasting LDLc), respectively. CONCLUSIONS: If confirmed in larger studies, nonfasting non-HDLc may be a suitable proxy for fasting LDLc in patients with T2DM.
|
Authors | Kathleen M Dungan, Tia Guster, Darren A DeWalt, John B Buse |
Journal | Current medical research and opinion
(Curr Med Res Opin)
Vol. 23
Issue 11
Pg. 2689-95
(Nov 2007)
ISSN: 1473-4877 [Electronic] England |
PMID | 17892636
(Publication Type: Comparative Study, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
|
Topics |
- Diabetes Mellitus, Type 2
(blood)
- Fasting
- Humans
- Lipids
(blood)
- Lipoproteins
(blood)
|